Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Doron Therapeutics

Request full access

Biologic therapies advancing osteoarthritis treatment with potent anti-inflammatory and regenerative capabilities

Chapel Hill, United StatesFounded 2024Biotech & Life Sciences

About Doron Therapeutics

Doron Therapeutics is a clinical stage biotechnology company focused on developing innovative treatments for osteoarthritis. The company specializes in a Phase 3 ready, intra-articular biologic drug derived from placental tissue, designed to deliver significant anti-inflammatory, tissue protective, and regenerative benefits. Doron Therapeutics primarily serves patients suffering from osteoarthritis, a progressive and degenerative joint disease. Operating in the biotechnology and healthcare market, the company employs a business model centered around the development and commercialization of advanced biologic therapies. Revenue generation is anticipated through successful clinical trials and eventual market approval, leading to sales of their lead product. The company was spun off from Bioventus in 2023, with Bioventus retaining a minority shareholder position. Despite financial challenges faced by Bioventus, Doron Therapeutics continues to advance its pipeline with a robust clinical database supporting its Phase 3 clinical study. Key management has successfully led the completion of Phase 2 studies, positioning the company as a leading player in osteoarthritis treatment.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Nov 2024 $11M $44M SPRIM Global Investments ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Doron Therapeutics website traffic

Latest recorded traffic for Doron Therapeutics is 280 monthly website visits, down 74.5% over the last three months.

Latest monthly visits280 3-month web change-74.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Doron Therapeutics in the Chapel Hill ecosystem

Live from Dealroom

The Doron Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • SPRIM Global Investments
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Doron Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Doron Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.